For research use only. Not for therapeutic Use.
Tosatoxumab（Cat No.:I042124）is an investigational monoclonal antibody designed to target and neutralize the toxin produced by Clostridium difficile (C. difficile), a bacterium responsible for causing severe gastrointestinal infections. By binding to the C. difficile toxins, Tosatoxumab prevents them from damaging the intestinal lining and causing inflammation. This treatment is being explored for use in patients with C. difficile infections, particularly those who are not responding to conventional therapies like antibiotics. Clinical trials are ongoing to assess its safety, effectiveness, and potential role in managing recurrent or severe C. difficile infections.
| Catalog Number | I042124 |
| CAS Number | 1374419-41-6 |
| Purity | ≥95% |
